Alivus Life Sciences Limited (ALIVUS) stock gains 5% intraday, bouncing back despite a weak 6-month trendline structure. Price at ₹1151.9.
Alivus Life Sciences Limited (ALIVUS) reports Q1 FY27 with 32% PAT growth, 25% margins, and revenue up 6.4% YoY.